KRMN · Karman Holdings Inc. · Insider Trading

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $36.99 to $37.52 per share. The reporting person undertakes to provide to the Karman Holdings Inc., any security holder of the Karman Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Represents the Reporting Person's grant of a Restricted Stock Unit (RSU) award under the Issuer's long term incentive program. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. Such shares will vest in three equal annual installments beginning on February 20, 2027.

With respect to 832 shares, represents the Reporting Person's annual grant of a Restricted Stock Unit (RSU) award under the Issuer's Non-Employee Director Compensation Policy for 2025. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. Such shares fully vested on February 13, 2026.

With respect to 1,531 shares, represents the Reporting Person's annual grant of a Restricted Stock Unit (RSU) award under the Issuer's Non-Employee Director Compensation Policy for 2026. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. Such shares will fully vest on January 1, 2027.

With respect to 431 shares, represents the Reporting Person's annual grant of a Restricted Stock Unit (RSU) award under the Issuer's Non-Employee Director Compensation Policy for 2025. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. Such shares will fully vest on July 24, 2026.

With respect to 1,531 shares, represents the Reporting Person's annual grant of a Restricted Stock Unit (RSU) award under the Issuer's Non-Employee Director Compensation Policy for 2026. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. Such shares will fully vest on January 1, 2027.

The shares represent the Reporting Person's annual grant of a Restricted Stock Unit (RSU) award under the Issuer's Non-Employee Director Compensation Policy for 2026. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. Such shares will fully vest on January 1, 2027.

With respect to 1,676 shares, represents the Reporting Person's grant of a Restricted Stock Unit (RSU) award under the Issuer's long term incentive program. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. 558 of the shares vested on January 1, 2026 and the remaining shares will vest in two equal annual installments beginning on January 1, 2027.

With respect to 9,188 shares, represents the Reporting Person's one-time grant of a Restricted Stock Unit (RSU) award in connection with his hiring. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. Such shares will vest in three equal annual installments beginning on May 7, 2027.

This line item is re-reported solely to allow the filing of this amendment. The Form 4 filed for the reporting person on May 26, 2026 inadvertently understated the number of shares of Common Stock issued to the reporting person by 69 shares. This amendment corrects the number of shares reported from 2,294 to 2,363 and sets forth the correct number of shares of Common Stock beneficially owned by the reporting person following the transactions reported in the Form 4 hereby being amended.

With respect to 832 shares, represents the Reporting Person's annual grant of a Restricted Stock Unit (RSU) award under the Issuer's Non-Employee Director Compensation Policy for 2025. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. Such shares fully vested on May 13, 2026.

With respect to 1,531 shares, represents the Reporting Person's annual grant of a Restricted Stock Unit (RSU) award under the Issuer's Non-Employee Director Compensation Policy for 2026. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. Such shares will fully vest on January 1, 2027.

With respect to 832 shares, represents the Reporting Person's annual grant of a Restricted Stock Unit (RSU) award under the Issuer's Non-Employee Director Compensation Policy for 2025. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. Such shares fully vested on February 13, 2026.

With respect to 1,531 shares, represents the Reporting Person's annual grant of a Restricted Stock Unit (RSU) award under the Issuer's Non-Employee Director Compensation Policy for 2026. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. Such shares will fully vest on January 1, 2027.

With respect to 25,728 shares, represents the Reporting Person's grant of a Restricted Stock Unit (RSU) award under the Issuer's long term incentive program. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. Such shares will vest in three equal annual installments beginning on February 20, 2027.

With respect to 74,209 shares, represents the Reporting Person's one-time grant of a Restricted Stock Unit (RSU) award in connection with his hiring. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. Such shares will vest in full on March 16, 2029.

With respect to 832 shares, represents the Reporting Person's annual grant of a Restricted Stock Unit (RSU) award under the Issuer's Non-Employee Director Compensation Policy for 2025. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. Such shares fully vested on February 13, 2026.

With respect to 1,531 shares, represents the Reporting Person's annual grant of a Restricted Stock Unit (RSU) award under the Issuer's Non-Employee Director Compensation Policy for 2026. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. Such shares will fully vest on January 1, 2027.

The shares represent the Reporting Person's grant of a Restricted Stock Unit (RSU) award under the Issuer's long term incentive program. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. Such shares will vest in three equal annual installments beginning on February 20, 2027.

The shares represent the Reporting Person's grant of a Restricted Stock Unit (RSU) award under the Issuer's long term incentive program. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. Such shares will vest in three equal annual installments beginning on February 20, 2027.

With respect to 431 shares, represents the Reporting Person's annual grant of a Restricted Stock Unit (RSU) award under the Issuer's Non-Employee Director Compensation Policy for 2025. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. Such shares will fully vest on July 24, 2026.

With respect to 1,531 shares, represents the Reporting Person's annual grant of a Restricted Stock Unit (RSU) award under the Issuer's Non-Employee Director Compensation Policy for 2026. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. Such shares will fully vest on January 1, 2027.

The shares represent the Reporting Person's grant of a Restricted Stock Unit (RSU) award under the Issuer's long term incentive program. Each of these RSUs represents a contingent right to receive one share of the Common Stock upon settlement. Such shares will vest in three equal annual installments beginning on February 20, 2027.

This filing also constitutes a Form 4 "exit filing" for the reporting person as the reporting person is no longer subject to Section 16 under the Securities Exchange Act of 1934, as amended.

Sale of shares pursuant to Rule 10b5-1 Plan adopted on August 13, 2025.

Shares are directly held by Tandem Trust u/t/a dated July 27, 2024, of which Tony Koblinski is the primary beneficiary.

Sale of shares pursuant to Rule 10b5-1 Plan adopted on August 13, 2025.

Shares are directly held by Tandem Trust u/t/a dated July 27, 2024, of which Tony Koblinski is the primary beneficiary.

Sale of shares pursuant to Rule 10b5-1 Plan adopted on August 13, 2025.

Shares are directly held by Tandem Trust u/t/a dated July 27, 2024, of which Tony Koblinski is the primary beneficiary.

Sale of shares pursuant to Rule 10b5-1 Plan adopted on August 13, 2025.

Shares are directly held by Tandem Trust u/t/a dated July 27, 2024, of which Tony Koblinski is the primary beneficiary.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.57 to $60.25. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Shares are directly held by Sundowner Trust u/t/a dated November 11, 2024, of which Mike Willis is the primary beneficiary.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.27 to $67.22. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $67.22. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.1400 to $70.1750. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Shares are directly held by RadzWest Capital LLC, of which Brian Raduenz is the Chief Executive Officer.

Concurrent with the consummation of the secondary offering by TCFIII Spaceco SPV LP of the Issuer's Common Stock, as previously reported by the Issuer on Form 8-K dated July 23, 2025 (the "Secondary Offering"), TCFIII Spaceco SPV LP effected a distribution in-kind consisting of all shares of Common Stock held by TCFIII Spaceco SPV LP not sold in the Secondary Offering (the "Trive LP Distribution") to Trive Capital Fund III LP ("Trive Fund III") and Trive Capital Fund III-A LP ("Trive Fund III-A") and Trive Fund III and Trive Fund III-A effected a pro rata distribution-in-kind of such shares of Common Stock to its partners for no consideration. In the distribution in-kind, the Reporting Person received 3,501,433 shares of Common Stock for no consideration.

Concurrent with the consummation of the secondary offering by TCFIII Spaceco SPV LP of the Issuer's Common Stock, as previously reported by the Issuer on Form 8-K dated July 23, 2025 (the "Secondary Offering"), TCFIII Spaceco SPV LP effected a distribution in-kind consisting of all shares of Common Stock held by TCFIII Spaceco SPV LP not sold in the Secondary Offering (the "Trive LP Distribution") to Trive Capital Fund III LP ("Trive Fund III") and Trive Capital Fund III-A LP ("Trive Fund III-A") and Trive Fund III and Trive Fund III-A effected a pro rata distribution-in-kind of such shares of Common Stock to its partners for no consideration. In the distribution in-kind, the Reporting Person received 54,796 shares of Common Stock for no consideration.

On July 25, 2025, TCFIII Spaceco SPV LP sold 20,473,968 shares of Common Stock at a price of $49.00, before deducting underwriting discounts and commissions, in connection with a registered underwritten offering and granted the underwriters a standard overallotment option for an additional 3,150,000 shares, which overallotment was exercised in full (such sale in the registered underwritten offering and overallotment option, collectively the "Secondary Offering"). Concurrent with the consummation of the Secondary Offering (the "Distribution Date"), TCFIII Spaceco SPV LP effected a distribution in-kind consisting of all shares of Common Stock held by TCFIII Spaceco SPV LP not sold in the Secondary Offering (the "Trive LP Distribution") to Trive Capital Fund III LP ("Trive Fund III") and Trive Capital Fund III-A LP ("Trive Fund III-A") for no consideration and Trive Fund III and

(Continued from footnote 1) Trive Fund III-A effected a pro rata distribution-in-kind of such shares of Common Stock to its partners for no consideration. If requested by any limited partner of Trive Fund III (each, a "Trive LP") in connection with the Trive LP Distribution, TCFIII Spaceco SPV LP may continue to manage the shares for such Trive LP following the Trive LP Distribution (and, as a result, TCFIII SpaceCo SPV LP may continue to have voting and dispositive power over such shares). As of the Distribution Date, TCFIII Spaceco SPV LP has no pecuniary interest in any shares of Common Stock.

Shares reported herein are directly held by TCFIII Spaceco SPV LP. Trive Capital Holdings LLC (which we refer to as "Trive Holdings") ultimately has voting control over TCFIII Spaceco SPV LP. Each of Messrs. Conner Searcy and Christopher Zugaro, as a manager of Trive Holdings, has voting control over Trive Holdings. As a result of the foregoing, each of Mr. Searcy, Mr. Zugaro,

(Continued from footnote 3) and Trive Holdings may be deemed to have beneficial ownership (as determined under Section 13(d) of the Exchange Act) of the securities directly held by TCFIII Spaceco SPV LP. Each of Trive Holdings and Messrs. Searcy and Zugaro disclaims beneficial ownership of any shares owned by TCFIII Spaceco SPV LP, except to the extent of its or his pecuniary interest therein. David Stinnett, a Partner of Trive Capital Management LLC, serves on the Board of Directors of the Issuer (the "Board"), together with John Hamilton, a Vice President of Trive Capital Management LLC.

These shares of the Issuer's Common Stock were sold by the Reporting Person pursuant to a registered public offering that closed on July 25, 2025, at a price of $49.00, before deducting underwriting discounts and commissions.

These shares of the Issuer's Common Stock were sold by the Reporting Person pursuant to a registered public offering that closed on July 25, 2025, at a price of $49.00, before deducting underwriting discounts and commissions.

Shares are directly held by Tandem Trust u/t/a dated July 27, 2024, of which Tony Koblinski is the primary beneficiary.

These shares of the Issuer's Common Stock were sold by the Reporting Person pursuant to a registered public offering that closed on July 25, 2025, at a price of $49.00, before deducting underwriting discounts and commissions.

This amendment is being filed to correct an error in reporting the amount of common stock beneficially owned following the registered public offering on July 25, 2025. The correct amount of common stock beneficially owned after the registered public offering is 344,105, not 378,137, as was originally reported on the Form 4 filed on July 29, 2025.

Shares are directly held by RadzWest Capital LLC, of which Brian Raduenz is the Chief Executive Officer.

On July 25, 2025, TCFIII Spaceco SPV LP sold 20,473,968 shares of Common Stock at a price of $49.00, before deducting underwriting discounts and commissions, in connection with a registered underwritten offering and granted the underwriters a standard overallotment option for an additional 3,150,000 shares, which overallotment was exercised in full (such sale in the registered underwritten offering and overallotment option, collectively the "Secondary Offering"). Concurrent with the consummation of the Secondary Offering (the "Distribution Date"), TCFIII Spaceco SPV LP effected a distribution in-kind consisting of all shares of Common Stock held by TCFIII Spaceco SPV LP not sold in the Secondary Offering (the "Trive LP Distribution") to Trive Capital Fund III LP ("Trive Fund III") and Trive Capital Fund III-A LP ("Trive Fund III-A") for no consideration and Trive Fund III and

(Continued from footnote 1) Trive Fund III-A effected a pro rata distribution-in-kind of such shares of Common Stock to its partners for no consideration. If requested by any limited partner of Trive Fund III (each, a "Trive LP") in connection with the Trive LP Distribution, TCFIII Spaceco SPV LP may continue to manage the shares for such Trive LP following the Trive LP Distribution (and, as a result, TCFIII SpaceCo SPV LP may continue to have voting and dispositive power over such shares). As of the Distribution Date, TCFIII Spaceco SPV LP has no pecuniary interest in any shares of Common Stock.

Shares reported herein are directly held by TCFIII Spaceco SPV LP. Trive Capital Holdings LLC (which we refer to as "Trive Holdings") ultimately has voting control over TCFIII Spaceco SPV LP. Each of Messrs. Conner Searcy and Christopher Zugaro, as a manager of Trive Holdings, has voting control over Trive Holdings. As a result of the foregoing, each of Mr. Searcy, Mr. Zugaro,

(Continued from footnote 3) and Trive Holdings may be deemed to have beneficial ownership (as determined under Section 13(d) of the Exchange Act) of the securities directly held by TCFIII Spaceco SPV LP. Each of Trive Holdings and Messrs. Searcy and Zugaro disclaims beneficial ownership of any shares owned by TCFIII Spaceco SPV LP, except to the extent of its or his pecuniary interest therein. David Stinnett, a Partner of Trive Capital Management LLC, serves on the Board of Directors of the Issuer (the "Board"), together with John Hamilton, a Vice President of Trive Capital Management LLC.

These shares of the Issuer's Common Stock were sold by the Reporting Person pursuant to a registered public offering that closed on July 25, 2025, at a price of $49.00, before deducting underwriting discounts and commissions.

Shares are directly held by Sundowner Trust u/t/a dated November 11, 2024, of which Michael Willis is the primary beneficiary.

These shares of the Issuer's Common Stock were sold by the Reporting Person pursuant to a registered public offering that closed on July 25, 2025, at a price of $49.00, before deducting underwriting discounts and commissions.

Shares are directly held by Sundowner Trust u/t/a dated November 11, 2024, of which Mike Willis is the primary beneficiary.

Shares are directly held by Tandem Trust u/t/a dated July 27, 2024, of which Tony Koblinski is the primary beneficiary.

Shares reported herein are directly held by TCFIII Spaceco SPV LP, of which Trive Capital Fund III LP (which we refer to as "Trive Fund III") and Trive Capital Fund III-A LP (which we refer to as "Trive Fund III-A") are limited partners of. Trive Capital Fund III GP LLC (which we refer to as "Fund III GP") is the general partner of Trive Fund III and has voting control over Trive Fund III. Fund III GP is the general partner of Trive Fund III-A and has voting control over Trive Fund III-A. Trive Capital Holdings LLC (which we refer to as "Trive Holdings") is the sole managing member of Fund III GP and has voting control over Fund III GP. Each of Messrs. Conner Searcy and Christopher Zugaro, as a manager of Trive Holdings, has voting control over Trive Holdings. As a result of the foregoing, each of Mr. Searcy, Mr. Zugaro,

(Continued from footnote 1) Trive Holdings, and Fund III GP may be deemed to have beneficial ownership (as determined under Section 13(d) of the Exchange Act) of the securities directly held by TCFIII Spaceco SPV LP. Each of Fund III GP, Trive Holdings and Messrs. Searcy and Zugaro disclaims beneficial ownership of any shares owned by TCFIII Spaceco SPV LP, except to the extent of its or his pecuniary interest therein. David Stinnett, a Partner of Trive Capital Management LLC, serves on the Board of Directors of the Issuer (the "Board"), together with John Hamilton, a Vice President of Trive Capital Management LLC. Solely for purposes of Section 16 of the Exchange Act, TCFIII Spaceco SPV LP, Trive Fund III and Trive Fund III-A may be deemed to be directors-by-deputization as a result of the service of such persons on the Board.

Shares are directly held by Koblinski Family Holdings, LLC, of which Tony Koblinski is the manager.